The Term Breech Trial

Actual title: Planned cesarean section versus planned vaginal birth for breech presentation at term: a randomized multicenter trial

Background:

  • Who did the study, and who published it?

    • Another large collaborative group study – the Term Breech Trial Collaborative Group

      • Primary authors of the group based in Canada

      • Participating sites spanned Europe, Canada, Australia, Central/South America, Africa, Middle-East, India & Pakistan

      • Funded by Canadian Institutes of Health Research (like Canada’s NIH)

  • Why was the study done?

    • As we covered in our ECV and breech birth podcasts, breech presentation affects about 3-4% of term pregnancies.

    • At the time this was conducted (published in 2000), it was a controversial question for delivery approach:

      • Cohort studies prior to this trial suggested that cesarean section was potentially better.

        • However, these cohort studies were potentially confounded by inclusion of pregnancies that would not be considered for breech birth (i.e., footling presentation) or by lack of experience with breech deliveries by the participating physicians. 

      • Two smaller RCTs prior to this trial and a meta-analysis did not find any substantial benefit to planned cesarean.

    • Thus this ambitious trial was carried out to determine which was truly better.

  • What was the research question?

    • “To determine whether planned cesarean section was better than planned vaginal birth for selected fetuses in the breech presentation at term.” 

Methods:

  • Who participated and when?

    • Enrollment between Jan 1997 and April 2000 at 121 centers in 26 countries.

    • Eligibility:

      • Breech presentation at or after 37 weeks → assigned to planned cesarean or planned vaginal delivery after consent by telephone system.

      • If assigned to CD group: planned CD was scheduled for 38+ weeks.

        • If patient presented in labor, CD was performed as soon as possible.

        • Presentation was confirmed again prior to cesarean and if cephalic, vaginal birth was then planned.

      • If assigned to VD group: management was expectant until spontaneous labor began, unless an indication to induce labor or a different reason for cesarean developed.

        • Labor management protocol was standardized (a LOT of standards):

          • Induction and amniotomy were allowed for standard OB indications

          • FHR monitoring by intermittent auscultation or cEFM

          • Augmentation with oxytocin was permitted, “so long as the clinician was confident that there was no evidence of cephalopelvic disproportion.”

          • Adequate labor progress in 1st stage was 0.5cm/h after onset of active labor, and in 2nd stage was descent of breech to pelvic floor within 2hr of full dilation, and delivery being imminent within 1hr of active pushing.

            • If fetal heart rate abnormalities were encountered or lack of progress in labor occurred, CD was performed.

          • Anesthesia choice was left to patient and providers.

          • Delivery means was recommended to have no intervention until spontaneous exit of the infant to the umbilicus, and minimum intervention thereafter with no traction on the body; and controlled delivery of the head using forceps or Mariceau-Smellie-Veit maneuver. 

            • Total breech extraction was not permitted.

        • Deliveries were to be attended by an “experienced clinician” – defined as someone who considered themselves to be skilled and experienced at vaginal breech delivery and confirmed by their department head at their institution. 

          • Each clinician was assigned a code number prior to study enrollment and there was info recorded on their qualifications and years of experience with breech delivery. 

  • What were they looking for?

    • Primary outcome: perinatal or neonatal mortality at less than 28 days of age, or one or more serious neonatal morbidities such as:

      • Birth trauma, such as subdural hematoma, IVH, spinal cord injury, basal skull fracture, peripheral nerve injury, or clinically significant genital injury; 

      • Seizures at less than 24h of age or requiring 2+ drugs to control; 

      • Apgar of less than 4 at 5 mins

      • Cord base deficit of 15 or greater

      • Hypotonia for at least 2 hours

      • Stupor, decreased response to pain, or coma

      • Intubation and ventilation for at least 24h

      • Tube feeding for four days or more

      • NICU admission longer than 4 days

    • Secondary outcome: maternal mortality or serious maternal morbidity for up to six weeks postpartum, such as:

      • PPH > 1500 cc or need for transfusion

      • D&C for bleeding or retained tissue

      • Hysterectomy

      • Cervical laceration involving lower uterine segment (if SVD)

      • Vertical incision or serious hysterotomy extension (if CD)

      • Vulvar or perineal hematoma requiring evacuation

      • DVT / PE

      • Pneumonia, ARDS

      • Wound infection requiring prolonged hospital stay, wound breakdown

      • Bladder / ureter / bowel injury requiring repair, or development of fistula

      • Bowel obstruction

      • Other serious morbidities

    • They also used multiple logistic-regression analyses to test for interactions between demographic / baseline characteristics and outcomes:

      • I.e., looking at the perinatal outcomes for babies, looked at interaction with maternal age, parity, type of breech presentation, gestational age, labor vs induction, EFW by US vs Leopold’s, etc. 

    • They also looked at center’s standard of care in “usual care” vs “high standard of care” environments (as determined by a pre-study survey) and maternal/perinatal mortality rate in the center’s country

      • High standard of care was defined as:

        • Having ability to perform a cesarean within 10 mins (vs 60 mins)

        • Personnel to bag-mask a baby available immediately (vs 10 mins)

        • Personnel to intubate / provide PPV to baby within 10 mins (vs 30 mins)

        • Ability to ventilate a baby for >24h (vs need for transfer for this)

Results:

  • Who was recruited?

    • 2088 pregnant patients were randomized, with 1043 assigned to CD and 1045 assigned to VD

      • Maternal outcomes were available for 1041 (CD) and 1042 (VD) groups

      • Neonatal outcomes were available for 1039 (CD) and 1039 (VD) groups

        • Overall very low loss to follow up!

    • Groups were overall very similar:

      • 52% in each group were nulliparous

      • EFW > 3kg in ~66% in each group (with 60% in each group estimated by ultrasound)

        • 21.9% in each group underwent attempted ECV

      • 35% of deliveries in each arm took place in “high standard of care” centers.

      • ~42% in each group presented in labor, and ~23% in each group had membranes ruptured on presentation.

      • Median GA at delivery was similar in each group (39w3d CD vs 39w6d VD)

    • In the planned CD group:

      • 90% had a CD, and 10% had a VD

    • In the planned VD group:

      • 43.3% had a CD, and 56.7% had a VD

        • CDs most commonly performed for:

          • Fetopelvic disproportion or abnormal progress in labor (50.1%)

          • Fetal heart rate abnormality (28.6%)

          • Footling breech presentation (15.3%)

          • Patient request (13.5%)

          • Medical or OB complication (10%)

          • Cord prolapse (2.7%)

      • ~15% of labor was induced, and ~50% of labor was augmented.

        • Only 9% had a protocol violation of labor management:

          • 3.6% for prolonged labor

          • 1.4% for footling or uncertain presentation of breech at delivery

          • 2.7% had no experienced clinician at delivery 

  • Outcomes:

    • Primary

      • There was a significantly lower risk of perinatal/neonatal morbidity in the planned cesarean group:

        • 17/1039 (1.6%) CD vs 52/1039 (5.0%) VD (RR 0.33)

          • This held true in both countries with low perinatal mortality rates and high perinatal mortality rates.

          • This difference lessened (but remained statistically significant) with increasing experience of the attending provider – that is, there was less risk of morbidity when more experienced personnel were present.

          • This difference also lessened (but remained statistically significant) when excluding induced/augmented labor, deliveries without a skilled clinician, and those with footling/uncertain breech presentation 

            • Bottom line: there is higher perinatal morbidity with planned VD, despite increasingly optimal environments in subanalyses

      • There were 3 neonatal deaths in the cesarean group, and 13 in the vaginal delivery group.

        • One of the CD group deaths was actually a vaginal birth with difficult delivery.

        • Two of the vaginal birth deaths were likely prior to enrollment; two were of neonates discharged from the hospital in good condition otherwise; and two were suspected intrapartum demises before a cesarean section could be started.

      • The reduction in perinatal morbidity was much greater in countries with lower perinatal mortality rates, despite a higher likelihood of cesarean birth in the VD groups in those countries

        • I.e., in an area with low perinatal mortality and a higher likelihood to get cut intrapartum, the benefit of planned CD was even greater

      • There was more birth trauma, seizures, hypotonia, low Apgars, cord blood acidemia, need for mechanical ventilation, and longer NICU stays in the planned vaignal delivery group. 

      • Birth weight over 4000g was more likely in the VD group (5.8% vs 3.1%). 

    • Secondary

      • No major group differences in maternal morbidity/mortality. 

Impact

What was the impact of all of this, and what are we doing now?

  • Well you kind of know already – how many planned breech births have you done?

    • For most of us, that answer is probably 0 “planned” and maybe 1 or 2 “unplanned.”

  • This was absolutely a practice-changing paper – and has guided how we approach the patient with breech presentation at term ever since.

  • What criticisms exist of this trial?

    • High number of patients were randomized in labor, and questionable counseling:

      • ~42% in each arm – this begs the question about how “planned” each method actually was, and how much counseling or selectivity may have been realistically applied to each patient.

      • Can also see this in the higher rate of >4kg babies in the VD arm, as well as only 20% in each arm had an attempt at ECV. 

    • Standard of care was not consistent

      • Continuous EFM (for better or worse) was not standard

      • Fetal weight and attitude of the head, while recorded for trial data, did not have to be assessed by US

      • Generalizability is hard to interpret with the pooled results:

        • I.e., would you take your chances on a breech in Australia with a well-counseled patient with CTG in a place where you can do a C-section in under 10 minutes and have highly qualified neonatal staff immediately available? Or in another location where you can’t do a c-section even by 60 minutes? 

          • The subgroup analyses by perinatal mortality rate of countries tried to answer that, but it is curious they didn’t choose to divide it up by their “high standard” versus “usual standard” centers.

        • Subsequent analysis has shown that 30% of the morbidity/mortality in the VD group can be attributed to the 6.7% of vaginal deliveries attended by no experienced provider – also calling into question the impact of experience. 

    • Enrollment scheme:

      • Units would call to centralized location to get allocation and this was not stratified by center – theoretically, a highly experienced obstetrician could call and end up with randomization to cesarean each time, and likewise an inexperienced one could call and randomize to vaginal delivery each time.

    • Numerous protocol violations and enrollment questions

      • Included initially in the trial were: 2 demised infants, 2 sets of twins, an anencephalic baby, a baby with spina bidfida, and another baby with suspected anomalies. 

      • 2 of the vaginal delivery group deaths were suspected to have been prior to randomization, yet counted in the perinatal mortality. 

        • And a number of other deaths in the VD arm may not have been related to the delivery itself – i.e., SIDS, GI issues, anomalies, inadequate respiratory resuscitation or resources.

What about doing breech births? Can we? / should we?

  • We don’t recommend breech birth – that would be irresponsible to do outright!

  • Well counseled, well-selected patients in centers with experience in breech delivery, ability to perform cesarean, and provide immediate neonatal resuscitation – it may be reasonable, though this trial doesn’t totally answer that question based on problems with generalizability.

    • In the wake of this trial, the PREMODA study was performed in France and Belgium – a prospective observational study allowing providers to select mode of delivery where breech delivery was still an option/standard.

      • ⅔ of women were allocated to cesarean delivery, but 71% of those undergoing planned vaginal breech birth were successful. 

      • There was no difference in perinatal mortality/morbidity was noted between groups in this study – suggesting that rigorous protocols and assessment by those with experience may make breech birth safer.

Interesting critique of trial: https://www.ogmagazine.org.au/14/2-14/term-breech-trial/ 

Planned Home Birth


What is the history of home birth? 

  • Until recent history, the home was the place for birth! In fact, the term was not coined until the 19th century because until then, birth usually occurred at home and not in a birthing center or hospital.

    • In the United States, in 1900, close to 100% of births were at home 

    • In 1938, rates had fallen to 50%, and then fewer than 1% in 1955 

    • In other countries like the UK, the trend to non-home births was slower, but still occurred; IN the UK, 80% of births occurred at home in the 1920s, and only 1% in 1991 

    • In Japan, this happened much later: In 1950, 95% of births occurred at home, but only 1.2% in 1975 

    • However, recently between 2004-2009, the number of home births in the US increased by 41% 

  •  Where in the world are there still home births? 

    • Many countries! 

  • So why did home births decrease over the years?

    • Hard to know exactly why 

    • There is some increased medicalization of birth 

    • In the hospital, there was the promise of anesthesia – ie. you could get an epidural 

    • At the same time, there was a trend of decrease maternal mortality and morbidity as well as decreased infant morbidity 

Why is there an increased movement to home birth? 

  • One note 

    • We want to discuss planned home births, not unplanned ones! 

  • Lots of reasons 

    • Some birthing people like the familiar environment of their home, and do not like the medically centered birth experience 

    • Some people feel it is more relaxing at home 

    • In one study published in the Journal of Midwifery and Women’s Health the top five reasons were: 

      • Safety 

      • Avoidance of unnecessary medical interventions 

      • Previous negative hospital experiences 

      • More control 

      • Comfortable and familiar environments 

    • One other study found that women experienced pain differentially and less negatively in the home setting 

  • This speaks to some of the things that we in hospitals or even birth centers can do to make patients feel safer and more comfortable! 

    • Clearly, some patients do not feel safe in the hospital setting, even though as doctors, we would argue that the hospital is the “safest” place to deliver a baby because of quick access to resources (ie. blood banks, ORs, NICUs) 

    • So I think this study gives us a good way to figure out what we can do in the hospital to make patients feel more comfortable

    • See our episode on limiting interventions in birth! 

  • What about now? Where in the US is there increases in home birth?

    • Top five in 2020:

      • Idaho (3.2%) 

      • Vermont (3%) 

      • Wisconsin (2.8%) 

      • Montana (2.6%) 

      • Utah (2.6%) 

So, now that we know there is increased desire for home birth, what is the evidence for or against home birth? 

  • A word on the evidence

    • Our gold standard is of course to have a randomized controlled trial, but you really can’t do that ethically for home birth! 

    • So most data is from observational studies, but they are often limited by methodological problems, including small sample size, lack of appropriate control group, reliance on birth certificate data, reliance on voluntary submission of data or self-reporting, limited ability to distinguish accurately between planned and unplanned home births, and variations in skill, training, and certification of birth attendants etc.  

The data for home birth for moms 

  • Patients don’t want unnecessary interventions — and look at all the interventions we do!

  • Even in TOLACers it seems that we do a lot – maybe it’s safe to TOLAC at home  

    • In England, women planning a home trial of labor after cesarean exhibited fewer obstetric risk factors, more likely to deliver vaginally, and had similar maternal and perinatal outcomes compared with those planning hospital TOLAC 

The data against home birth for moms 

  • Most research about home birth cohorts recently have strict selection criteria for appropriate candidates

    • So remember: these studies usually select so that there is absence of preexisting maternal disease, absence of significant disease arising in pregnancy (so think of all your GDMs! Your hypertensives!), singleton fetus, cephalic presentation, gestational age >36 or 37 weeks and less than 41-42, labor is spontaneous 

  • Finally, while in many other countries they may have safe methods of identifying risk and reasons to get moms to the hospital, most places in the US do not have this 

    • The relatively low rates of morbidity and mortality reported for planned home births from Ontario, British Columbia, and the NEtherlands were from highly integrated health care systems with established criteria and provisions for emergency intrapartum transport 

    • In the US, however, the home birth attendant (midwife, etc) do not always have hospital privileges or are not connected to a doctor that has hospital privileges 

    • There is not a safe and timely way to transfer the patient intrapartum to the hospital if needed 

    • There is also a reported risk of needing intrapartum transport to hospital of 23-37% for nulliparous women and 4-10% for multiparous women 

    • Reasons for transport: lack of labor progress, nonreassuring fetal status, need for pain relief, hypertension, bleeding, and fetal malposition 

Conclusion: It does appear that home births can be safe for mom, but only in a selected populations. We would recommend that if someone desires to have a home birth, that they have a birth attendant that is a certified nurse midwife (CNM) or a physician who practices obstetrics within an integrated and regulated health system. They should also have a plan about when and how to come into the hospital if there are complications. 

They should also be a specifically selected population:

  • Absence of preexisting maternal disease 

  • Absence of significant disease during pregnancy 

  • Singleton fetus 

  • Cephalic presentation 

  • Term gestation, and not post dates 

  • Spontaneous labor 

  • No uterine scars (ie. no TOLAC) 

That data for home births for babies 

  • While we can see that in previous data, there was some increased risk of neonatal morbidity and mortality, there was a recent big paper that looked at 10,609 births that came out in the Green Journal in November 2021, published by midwives in Washington state 

  • https://journals.lww.com/greenjournal/pages/articleviewer.aspx?year=2021&issue=11000&article=00002&type=Fulltext

  • Basically, they compared planned home births (40.9% of the population they studied) vs. planned birth center births (59.1%) 

    • Their results were really great! Not only did they have a C/S rate of 11.4% for the nulliparous women and 0.87% for the multiparous women, the perinatal mortality rate after onset of labor was 0.57/1000 (super low, compared even to older data)

    • Compared to planned birth center births, planned home births had similar risks in crude and adjusted analyses 

    • Overall, numbers were low anyway for 

  • The data against home births for babies 

    • That’s all well and good for Washington

    • But let’s not forget that these women were carefully selected for a planned home birth 

      • They followed ACOG’s guidelines 

      • If we look at the demographics, most of these women were <35 (only 21% were 35 or older) 

      • These women were thin (63% had normal BMIs, and only 14% had BMIs >30) 

      • Most of them were white (83.8%) 

      • They likely were of higher social class (62% had commercial insurance) 

      • Most of them were multiparous (63.9%, and 8.4% had >4 prior births) 

      • Only 3.2% had gestational diabetes

      • Basically, very healthy population that not all people fit the mold for 

    • There is a lot more increased perinatal morbidity for babies in other data! And mortality!

      • Basically: there is about a 2.43x risk of perinatal mortality if we look at all data and a 3x increase risk of neonatal seizures or serious neurological dysfunction 

      • Overall, yes these numbers are small (death is 1-2/1000 and seizures/neurological dysfunction is 0.4-0.6/1000)  

      • Even in this study from Washington state, nulliparous women had a 1.04/1000 birth perinatal mortality rate

Conclusions: Again everyone has the right to choose what type of birth they have. However, if we look at data as a whole, neonatal outcomes are overall worse with planned home births overall compared to in hospital births. While these outcomes are overall low, patients should still be counseled the risk of perinatal death is approximately 2x higher in planned home birth and neonatal seizures/neurological dysfunction is about 3x higher. It’s likely that these outcomes can be mitigated in the right population with a good plan to transfer patients/babies to a hospital and with the right birth attendant. 

However, the fact remains that there is not always infrastructure in place to make sure that all of these things can happen. 

Therefore, it’s important to discuss these studies with your patients and especially review with them if they are a good candidate or not. Remember they should also be a specifically selected population:

  • Absence of preexisting maternal disease 

  • Absence of significant disease during pregnancy 

  • Singleton fetus 

  • Cephalic presentation 

  • Term gestation, and not post dates 

  • Spontaneous labor 

  • No uterine scars (ie. no TOLAC) 

Limiting Intervention in Labor and Birth

Check out ACOG CO 766 for more on this subject!

Patients in labor and delivery have more information (whether accurate or inaccurate) than ever before to inform their opinions, choices, and risk tolerance.

  • One certainty - more patients are choosing birth centers and home birth as a perceived way to reduce intervention and promote physiologic labor

  • Today we review practices that are worth reviewing on your unit to limit intervention, when appropriate, in a generally low-risk patient; we are not advocating for non-intervention, to be clear! 

Coping in Labor Techniques

Continuous Emotional Support in Labor

  • Randomized trial evidence supports use! 

  • Continuous labor support:

    • Shorter labor

    • Decreased need for analgesia

    • Fewer operative deliveries

    • Fewer reports of dissatisfaction with experience 

    • Less cesarean (RR 0.75 in Cochrane review) → suggesting potential for cost-effectiveness

    • Less likely to have 5-minute Apgar <7 (RR 0.62)

  • Continuous labor support can come in the form of:

    • Doulas: individuals with some degree of training in continuous labor support

      • There are official doula certification programs, as well as those who are truly “lay doulas” if you will.

    • Friends/family: an RCT of 600 patients demonstrated teaching labor support techniques to friends/family in labor room was effective, reducing labor duration and had higher Apgar scores.

    • Tech? The pandemic has definitely increased interest in virtual or mobile doula apps… though evidence is sparse.

Nonpharmacologic Techniques for Coping

  • “Coping” -- a better and more complete way to assess labor pain, and denotes some normal, physiologic discomfort with labor. 

    • Asking the patient how they are “coping” also can provide a way to assess other factors which may influence pain or its experience, such as anxiety or support.

  • Few non-pharmacologic techniques have been well-studied to determine effectiveness or comparative effectiveness. There are trials, but with substantial heterogeneity in their techniques and application. 

    • However, some options:

      • Water immersion: has been shown in observational trials to lower pain scores without evidence of harm in 1st stage of labor

      • Intradermal sterile water injections

      • Acupuncture/massage

      • TENS (transcutaneous electrical nerve stimulation)

      • Aromatherapy

      • Audioanalgesia

      • Additional shout out to Rebcca Dekker, PhD RN, who runs the Evidence Based Birth website and has a really excellent and frequently updated series on pain management in labor

        • Her book, Babies Are Not Pizzas, is also a worthwhile look at our own potential biases as obstetricians / trainees from a combined patient and birth professional perspective.

Obstetrical Management of Labor and Delivery

Latent Labor: When to admit?

  • We’ve all been there: on the fence about whether and when to admit the patient in latent or early labor.

  • Observational trials associate early admission with:

    • More labor arrest

    • More oxytocin use

    • More IUPC use

    • More antibiotic use for fevers

    • More cesarean delivery in active phase

      • Importantly, these studies cannot determine whether this was directly associated with presenting to the hospital for care, or if those with a “dysfunctional” latent phase are more likely to present and thus skew these results.

  • RCTs:

    • Delayed (awaiting active phase) vs early (on presentation) admission:

      • Delayed group had lower rates of epidural use and labor augmentation

      • Delayed group had greater satisfaction

      • Delayed group spent less time in L&D

      • NO difference in operative delivery, cesarean delivery, and newborn outcomes (though too small to be powered sufficiently).

    • ARRIVE trial

      • Induction at 39 weeks versus awaiting spontaneous labor/medical induction

        • LESS cesarean delivery in 39 week IOL group (18.6 vs 22.2%)

        • NO difference in neonatal outcomes

          • Rates of spontaneous labor in the expectant management group are not reported/compared, and admission practices in this group are not reported (i.e., rate of early admission in latent labor / need for augmentation / etc)

          • So ARRIVE trial does not answer the question of whether spontaneous labor is better, but does provide a data point to suggest equipoise/potential benefit between 39 week induction and awaiting spontaneous labor, whether it comes or not. 

            • Important to keep in mind as you counsel patients re: 39 week inductions.

    • Admission may be necessary for a variety of reasons, including pain management and fatigue, and this can be used as a time to implement/supplement coping strategies (as previously discussed)

Term Prelabor Rupture of Membranes (PROM): To Induce or Not to Induce?

  • A super common scenario, in which there are a number of potential patient questions:

    • Do I need to induce right away, or can I wait for spontaneous labor?

    • If I wait, how long can I wait?

    • If I don’t wait, what is the best method to start labor?

  • Historical studies have demonstrated ~78% of patients will labor within 12 hours, and 95% in 24-28 hours after PROM.

    • TERMPROM RCT: induction vs expectant management of PROM

      • 4-armed RCT: immediate induction arms (oxytocin vs prostin gel), and expectant mgmt arms (where given up to 4 days PROM’d or clinical concern for chorio before being induced).

      • Median time to delivery for expt mgmt arms were 33 hrs, 95% delivering by 94-107 hours after rupture.

  • However, immediate induction can reduce other risks (based on systematic review, where 60% of patients were TERMPROM trial):

    • Decreased time to delivery by 10 hours

    • Chorioamnionitis / endometritis decreased (RR 0.49)

    • Early onset neonatal sepsis decreased (RR 0.73)

    • NICU admission decreased (RR 0.75)

      • Importantly, the overall quality of evidence for neonatal outcomes in particular is low, and additional RCTs in this space are welcomed! 

  • In terms of methods, TERMPROM noted that # of vaginal exams and fever risks were slightly less overall with oxytocin

    • Though the prostaglandin used here was vaginal gel, so likely increased # of exams

    • Time to delivery was similar in both groups

    • Other trials have not found significant benefits to prostaglandin vs oxytocin

    • Some other trials have evaluated balloon catheter use in PROM

      • Potentially increased infection risk, especially if used alone (9.7% vs 2.9% in oxytocin alone)

      • With respect to combining balloon with pharmacologic agent, appears to be no benefit to ballon + oxytocin vs oxytocin alone (though small numbers overall evaluating this)

  • So back to our initial questions:

    • Do I need to induce right away, or can I wait for spontaneous labor?

    • If I wait, how long can I wait?

    • If I don’t wait, what is the best method to start labor?

      • It’s reasonable to wait some time for spontaneous labor, based on TERMPROM data suggesting almost 80% of patients will labor by 12 hours after PROM. 

        • However, patients should be aware of potentially increased risk 

        • If GBS+, patients should be started on PCN to reduce neonate GBS sepsis risk.

      • Oxytocin seems to be the best agent, though evidence is somewhat limited overall.

Intermittent Auscultation of Fetal Heart Rate

  • cEFM has unfortunately not been shown to significantly affect outcomes like perinatal death or cerebral palsy rates, but has become entrenched in OB practice.

  • IA can be used in low risk patients and potentially decrease risk of cesarean:

    • Cochrane review of 13 RCTs, cEFM vs IA. cEFM:

      • Increased CD risk (RR 1.63)

      • Increased operative vaginal delivery risk (RR 1.15)

      • Decreased risk of early neonatal seizures (RR 0.50)

      • No difference in rates of CP or neonatal death, and no difference in outcomes at 4 years of age.

    • Low risk is very important to define! Inclusion criteria for IA varies by institution, but generally:

      • No meconium staining, intrapartum bleeding, or abnormal fetal testing before admission

      • No fetal conditions that may increase risk (i.e., anomalies, FGR)

      • No maternal conditions that may increase risk (i.e., TOLAC, DM, HTN)

      • No requirement for induction or augmentation of labor (i.e., spontaneous normal labor only)

  • ACNM and Association of Women’s Health, Obstetric, and Neonatal Nurses (AWHONN) have excellent guidelines and protocols for IA for nursing in particular.

Routine Amniotomy

  • Depending on where you are and practice patterns, this might be one of the most controversial things in labor management! 

  • “Routine amniotomy in spontaneous labor” 

    • Notably, this separates out when amniotomy is indicated, such as to facilitate FSE/IUPC or for slow labor progress in combination with oxytocin. 

    • This essentially is looking at just the role of amniotomy then in spontaneous labor

  • Amniotomy alone:

    • Doesn’t shorten duration of spontaneous labor

    • Doesn’t reduce incidence of cesarean

    • Doesn’t reduce patient satisfaction

    • Doesn’t reduce rates of 5 min Apgar score <7

    • Doesn’t increase rates of abnormal FHR pattern

    • Doesn’t increase rates of cord prolapse

  • So is there a reason?

    • Not to do routinely -- reserve in spontaneous labor to facilitate monitoring or interventions if indicated

  • How about within the context of labor induction?? -- that’s what you’re really wanting to know!

    • 14 trial meta-analysis:

      • When used alongside oxytocin:

        • Decreased length of first stage of labor (1.11 hrs)

        • Modest reduction in cesarean birth rate (RR 0.87 vs expectant mgmt)

    • 4 trial meta-analysis comparing “early” vs “late” amniotomy after cervical ripening:

      • Early = before active phase; late = after active phase, or awaiting SROM

        • Similar rates of cesarean (RR 1.05)

        • Early amniotomy with faster interval to delivery (5 hours)

        • SVD rates overall similar between groups, though technically reduced in early group on basis of single trial (67.5% vs 69.1%)

        • No increased risk of cord prolapse, hemorrhage, abruption, chorio, neonatal outcomes 

      • Takeaway:

        • AROM is reasonable, when indicated to facilitate monitoring, especially if oxytocin already started.

        • May reduce time to delivery without necessarily increasing other risks.

        • Very little data to guide this overall, so more study welcomed!

Immediate versus Delayed Pushing

  • The CO qualifies and speaks specifically to nulliparous patients with epidural analgesia being allowed to “passively descend” or “labor down” once identified to be 10cm.

    • The potential benefit to this is to allow the fetus to passively rotate and descend in the pelvis and conserve maternal energy.

  • Importantly, studies that have looked at risk of adverse outcomes with length of second stage (i.e., Consortium on Safe Labor data informing the ACOG/SMFM Obstetric Care Consensus about recommended length of time to push) do not take into account duration of passive descent vs active pushing, just total time in 2nd stage.

  • Data reviewed in the CO:

    • 2 meta-analyses of RCTs demonstrate delayed pushing 1-2 hours:

      • Increases length of 2nd stage by approx 1 hour

      • Decreases pushing length by approx 20 minutes

      • No difference in SVD rate

    • Recent 2018 RCT that you probably saw in JAMA, delay pushing 60 mins vs immediate pushing (again in nullips with an epidural):

      • Trial stopped before intended recruitment because of increased morbidity in the delayed group.

      • No difference in SVD rate

      • Immediate pushing resulted in:

        • Lower rates of chorio (RR 0.7)

        • Lower rates of PP hemorrhage (RR 0.6)

        • Lower risk of neonatal acidemia (RR 0.7)

  • Overall, delayed pushing in the nullipara with an epidural seems to not confer benefit, and likely increases risk for harm.